Streetbeat News

Regulatory

KNW

Know Labs, Inc. (NYSE:KNW) announced a new study showing improved accuracy of its Bio-RFID sensor technology for non-invasive blood glucose monitoring. The study used a lightGBM machine learning model, achieving a Mean Absolute Relative Difference (MARD) of 12.9%, within the range of FDA-cleared blood glucose monitoring devices.

Portfolio Pulse from Happy Mohamed

May 30, 2023 | 1:20 pm

HUDA

Hudson Acquisition I Corp. (NASDAQ:HUDA) received a notice of deficiency from Nasdaq due to delayed filing of its Form 10-Q and pending filing of its 10-K. The company has until June 20, 2023, to submit a plan to regain compliance and has replaced its former auditor to rectify the situation.

Portfolio Pulse from Happy Mohamed

May 30, 2023 | 1:19 pm

HPCO

Hempacco Co. (NASDAQ:HPCO) received a notice from Nasdaq for non-compliance with Listing Rule 5250(c)(1) due to not filing its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023. The company has 60 days to submit a plan to regain compliance or face potential delisting.

Portfolio Pulse from Happy Mohamed

May 30, 2023 | 1:17 pm

FXI

SPY

TSLA

Tesla CEO Elon Musk opposes the decoupling of the U.S. and China, according to Beijing officials. Musk's statement comes during his visit to China, where he met with government officials and discussed Tesla's expansion plans.

Portfolio Pulse from Happy Mohamed

May 30, 2023 | 1:08 pm

INBX

Inhibrx, Inc. (NASDAQ:INBX) has been granted Fast Track designation by the FDA for INBRX-101, a treatment for patients with emphysema due to alpha-1 antitrypsin deficiency (AATD).

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 1:07 pm

SPY

VGK

Russia's Foreign Ministry stated that the country has the right to take the harshest measures in response to a drone attack on Moscow, according to Reuters citing RIA.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:57 pm

IOVA

Iovance Biotherapeutics' stock is trading higher after the FDA accepted its Biologics License Application for lifileucel, a TIL therapy for advanced melanoma patients. Analysts from Stifel, Chardan Capital, and HC Wainwright & Co. maintained Buy ratings and raised price targets.

Portfolio Pulse from Adam Eckert

May 30, 2023 | 12:52 pm

IOVA

Iovance Biotherapeutics' shares are trading higher after the FDA accepted the company's Biologics License Application for lifileucel.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:48 pm

ZIVO

Zivo Bioscience (NASDAQ:ZIVO) has received an updated dossier reaffirming its GRAS (Generally Recognized As Safe) designation for its proprietary algal biomass product as a human food ingredient. The GRAS status allows manufacturers and marketers to safely integrate ZIVO's algal biomass into food processing lines and products.

Portfolio Pulse from Happy Mohamed

May 30, 2023 | 12:47 pm

GFS

GlobalFoundries' New York facility has been accredited by the U.S. Department of Defense as a Category 1A trusted supplier to manufacture semiconductors.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:41 pm